Published in Isr J Med Sci on February 01, 1986
Yellow nail syndrome. Postgrad Med J (1997) 1.16
Titanium, sinusitis, and the yellow nail syndrome. Biol Trace Elem Res (2010) 1.13
Role of Titanium in the Development of Yellow Nail Syndrome. Skin Appendage Disord (2015) 0.93
Yellow Nail Syndrome: Report of a Case Successfully Treated with Octreotide. Tanaffos (2015) 0.78
Yellow nail syndrome and xanthogranulomatous pyelonephritis. Postgrad Med J (1995) 0.77
Yellow Nail Syndrome and Nail Lichen Planus may be Induced by a Common Culprit. Focus on Dental Restorative Substances. Front Med (Lausanne) (2014) 0.75
Clinical problem-solving. Testing, testing, testing.... N Engl J Med (1995) 3.45
Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet (1982) 2.34
Native valve Staphylococcus epidermidis endocarditis: report of seven cases and review of the literature. Am J Med (1991) 1.85
Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis (2004) 1.81
Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRL-lpr/lpr mice by heparin. Arthritis Rheum (1990) 1.60
The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. Circulation (1966) 1.54
The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol (1999) 1.53
Systemic lupus erythematosus induced by ovulation induction treatment. Arthritis Rheum (1994) 1.50
Brucellosis in patients with heart disease: when should endocarditis be diagnosed? Cardiology (1990) 1.46
Thoughts on the proposed links between Behçet's disease and familial Mediterranean fever. Clin Exp Rheumatol (2002) 1.45
High frequency of hemorrhagic strokes in Jerusalem during the Persian Gulf War. Neurology (1992) 1.43
A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr (1999) 1.42
Lymphoma and systemic sclerosis--an uncommon association or possible coincidence of two disorders with a fatal outcome. Eur J Haematol (1997) 1.42
Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts. Eur J Neurol (2011) 1.42
Malignant melanoma in Turner's syndrome. Int J Dermatol (1993) 1.41
Familial Mediterranean fever in the "Chuetas" of Mallorca--origin in inquisition? Isr J Med Sci (1995) 1.39
Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest (1989) 1.36
Nephrotic syndrome associated with amyloid-like glomerular deposits. Nephron (1977) 1.33
Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum (2001) 1.17
Detection and characterization of hepatitis B virus DNA in serum of HBe antigen-negative HBsAg carriers. J Med Virol (1984) 1.14
Granulomatous hepatitis accompanying a self-limited febrile disease. Lancet (1968) 1.11
The liver in amyloidosis. Digestion (1974) 1.11
Integration of family medicine into university teaching hospital in Israel: a pilot project. Br Med J (1974) 1.07
Liver involvement in giant cell arteritis. Clin Rheumatol (1993) 1.06
Dermatomyositis associated with the recurrence of transitional cell carcinomas and Kaposi's sarcoma. Clin Exp Rheumatol (1991) 1.05
Hospital admissions due to adverse drug reactions: a comparative study from Jerusalem and Berlin. Eur J Clin Pharmacol (1980) 1.04
Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch Intern Med (1981) 1.02
Non-response to colchicine in FMF--definition, causes and suggested solutions. Clin Exp Rheumatol (2008) 1.02
Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever). Am J Med Sci (1981) 1.01
Thrombocytosis in rheumatoid arthritis. Recurrent arterial thromboembolism and death. Ann Rheum Dis (1977) 1.00
Immunogenetics of rheumatoid arthritis in Israel. Tissue Antigens (1986) 0.99
Renal manifestations in recurrent polyserositis (familial Mediterranean fever). Isr J Med Sci (1970) 0.98
Intrahepatic obstructive jaundice due to amyloidosis of the liver. A case report and review of the literature. Gastroenterology (1971) 0.98
Pulse wave velocity in healthy subjects and in patients with various disease states. Am Heart J (1971) 0.98
Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature. J Rheumatol (1989) 0.98
HLA antigens in Reiter's syndrome in Israeli patients. J Rheumatol (1985) 0.97
Familial mediterranean fever - a review and update. Minerva Med (2001) 0.96
Unusual presentation of familial Mediterranean fever: role of genetic diagnosis. Ann Rheum Dis (2000) 0.96
Idiopathic sclerosing peritonitis in a man. J Clin Gastroenterol (1990) 0.95
Immunological evaluation of asymptomatic carriers of hepatitis B virus. Clin Exp Immunol (1981) 0.94
Recurrent cholestatic jaundice of pregnancy. Report of five cases and electron microscopic observations. Arch Intern Med (1966) 0.94
Acute colchicine intoxication--possible role of erythromycin administration. J Rheumatol (1992) 0.94
A chicken caudal homologue, CHox-cad, is expressed in the epiblast with posterior localization and in the early endodermal lineage. Development (1991) 0.93
Coronary vasospasm associated with uncontrolled carcinoid tumour. J Intern Med (2000) 0.93
Plasma colchicine concentration in patients with recurrent polyserositis (familial Mediterranean fever) on long-term prophylaxis. Arthritis Rheum (1982) 0.92
The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families. Genet Test (2000) 0.92
Analysis of the work of nurse-practitioners in family practice and its effect on the physicians' activities. J Fam Pract (1977) 0.91
Lymphocyte subpopulations in chronic active hepatitis: increase in lymphocytes forming stable E-rosettes. Clin Immunol Immunopathol (1975) 0.91
Adverse reactions to drugs in hospitalized medical patients. A comparative study. Isr J Med Sci (1973) 0.91
Familial Mediterranean fever in the 'Chuetas' of Mallorca: a question of Jewish origin or genetic heterogeneity. Eur J Hum Genet (2000) 0.91
Long-term colchicine prophylaxis in familial Mediterranean fever. Br Med J (1977) 0.91
Effect of age on the expressed B cell repertoire: role of B cell subsets. Int Immunol (1993) 0.91
Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers. Br J Clin Pharmacol (1980) 0.90
Plasma total homocysteine levels in subjects with hyperinsulinemia. J Intern Med (2000) 0.90
The effect of colchicine treatment on sperm production and function: a review. Hum Reprod (1998) 0.90
Degenerative verrucous endocardiosis. A clinical-pathological study of 45 cases with reference to a protracted form of the disease. Isr J Med Sci (1967) 0.90
Gammopathy in liver disease. Prog Liver Dis (1972) 0.89
Fertility and obstetric history in patients with familial Mediterranean fever on long-term colchicine therapy. Br J Obstet Gynaecol (1987) 0.89
Hospital admissions due to adverse drug reactions. Am J Med Sci (1979) 0.89
Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain. J Immunol (1999) 0.89
[Prognostic factors in hepatic encephalopathy]. Harefuah (1982) 0.88
The syndrome of inappropriate antidiuretic hormone secretion in the elderly. Am J Med (1997) 0.87
Monocyte function in familial Mediterranean fever. Am J Med Sci (1978) 0.87
Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp Hematol (1996) 0.87
Dopamine-beta-hydroxylase activity in familial Mediterranean fever. Lancet (1990) 0.86
Non-A, non-B hepatitis not following transfusion: a study of hospital patients in Jerusalem. Isr J Med Sci (1982) 0.86
Latrogenic lipidosis following prolonged intravenous hyperalimentation. Am J Clin Nutr (1975) 0.86
Hypertension and ischemic heart disease in a rural family practice in Israel. J Fam Pract (1979) 0.86
Pyrin and cryopyrin--similar domain sequence but opposite inflammatory consequence. Clin Exp Rheumatol (2007) 0.86
Successful treatment of pure red cell aplasia in systemic lupus erythematosus with erythropoietin. J Rheumatol (1995) 0.86
Molecular analysis of HLA class II genes in primary Sjögren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients. Hum Immunol (1993) 0.86
Paroxetine associated hepatotoxicity: a report of 3 cases and a review of the literature. Pharmacopsychiatry (2002) 0.85
About colchicine compliance, resistance and virulence. Clin Exp Rheumatol (2009) 0.85
Chronic bronchitis and bronchial asthma in a rural community in Israel: relation to socioenvironmental factors. Isr J Med Sci (1979) 0.85
Syncope: a retrospective study of 101 hospitalized patients. Isr J Med Sci (1985) 0.85
Transient neutropenia induced by intravenous immune globulin. N Engl J Med (1992) 0.85
Prevalence of duodenal ulcer in a rural community in Israel. J Chronic Dis (1978) 0.85
Etiology, treatment, and prognosis of large pericardial effusions. A study of 34 patients. Chest (1991) 0.84
A cytogenic evaluation of long-term colchicine therapy in the treatment of Familial Mediterranean fever (FMF). Am J Med Sci (1978) 0.84
Macrophage cholesterol metabolism, apolipoprotein E, and scavenger receptor AI/II mRNA in atherosclerosis-susceptible and -resistant mice. Arterioscler Thromb Vasc Biol (2000) 0.84
Type B and non-B viral hepatitis in Jerusalem. Bull World Health Organ (1976) 0.84
Incidence of amyloidosis in recurrent polyserositis (familial Mediterranean fever). Isr J Med Sci (1970) 0.84
Colchicine intoxication: clinical pharmacology, risk factors, features, and management. Semin Arthritis Rheum (1991) 0.84
Nodular vasculitis associated with propylthiouracil therapy. Cutis (1992) 0.84
Azoospermia due to testicular amyloidosis in a patient with familial Mediterranean fever. Hum Reprod (2001) 0.84
Cell death in cultured human Saos2 osteoblasts exposed to low-density lipoprotein. J Cell Biochem (2003) 0.84
Obstructive jaundice associated with carcinoma of the prostate. Isr J Med Sci (1975) 0.83
Colchicine inhibits spermatozoal motility in vitro. Int J Fertil Menopausal Stud (1994) 0.83
Compound cardiac toxicity of oral erythromycin and verapamil. Ann Pharmacother (2001) 0.83
Failure of long-term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation. Chest (1991) 0.83
CHox E, a chicken homeogene of the H2.0 type exhibits dorso-ventral restriction in the proliferating region of the spinal cord. Mech Dev (1991) 0.83
Complete heart block and seizures in an adult with systemic lupus erythematosus. A possible pathophysiologic role for anti-SS-A/Ro and anti-SS-B/La autoantibodies. Arthritis Rheum (1993) 0.83
Dehydroepiandrosterone (DHEA) treatment reverses the impaired immune response of old mice to influenza vaccination and protects from influenza infection. Vaccine (1995) 0.83
Clinical implications of monoclonal gammopathy in chronic liver disease. Am J Dig Dis (1974) 0.83
Scavenger receptor activity and expression of apolipoprotein E mRNA in monocyte-derived macrophages of young and old healthy men. Atherosclerosis (1997) 0.82
Antimicrobial therapy in patients hospitalized in a medical ward. A report from the Boston Collaborative Drug Surveillance Program. Isr J Med Sci (1975) 0.82